RRX Pharma Nanotech Medical Device
Nanotech promises to revolutionise medicine, electronics,
chemistry and aerospace.
Initially the field of medicine will apparently use nanotechnology
most heavily, possibly drawing more from engineering and physics than from
traditional medicine.
While advanced engineering companies have manipulated quantum entities
in clusters they might now be tasked to build novel medical
devices particle by particle.
Nanominiaturisation may enable swarms of minuscule intelligent
agents to permeate the bloodstream delivering therapeutic
mechanics directly to target sites.
Prototype modeling considerations include BioMEMS capable
of surviving the hostile in vivo context.
We are optimistic that
this new approach will be successful and expect excellent return on investment.
|